loading

Kezar Life Sciences Inc (KZR) 財務データ

損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
期間の長さ 3 か月 3 か月 3 か月 3 か月 3 か月
Revenues
-
- - - -
Operating Expenses
18.24%
17.63
21.56 21.95 23.38 23.71
Operating Income/Loss
18.24%
-17.63
-21.56 -21.95 -23.38 -23.71
Income/Loss From Continuing Operations Before Tax
18.11%
-16.56
-20.22 -20.31 -21.55 -21.66
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
18.11%
-16.56
-20.22 -20.31 -21.55 -21.66
Net Income/Loss
18.11%
-16.56
-20.22 -20.31 -21.55 -21.66
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
222.77K%
7.3057
0.00328 7.2962 72.85 72.80
Diluted Average Shares
222.77K%
7.3057
0.00328 7.2962 72.85 72.80
Basic Earnings Per Share
18.05%
-2.27
-2.77 -2.78 -0.30 -0.30
Diluted Earnings Per Share
18.05%
-2.27
-2.77 -2.78 -0.30 -0.30
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$20.66
price down icon 2.36%
$84.81
price up icon 1.10%
$30.67
price up icon 4.57%
$98.62
price up icon 0.53%
$144.01
price up icon 1.67%
biotechnology ONC
$340.70
price up icon 2.36%
大文字化:     |  ボリューム (24 時間):